A new chromogenic agar medium, chromID VRE, to screen for vancomycin-resistant Enterococcus faecium and Enterococcus faecalis

被引：24

作者：

Ledeboer, Nathan A. ^{[1
]}

Tibbetts, Robert J. ^{[1
]}

Dunne, William A. ^{[1
]}

机构：

[1] Washington Univ, Sch Med, Dept Pathol & Immunol, Div Lab & Genom Med, St Louis, MO 63110 USA

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2007年 / 59卷 / 04期

关键词：

VRE; Enterococcus; chromogenic agar; bioMerieux;

D O I：

10.1016/j.diagmicrobio.2007.06.018

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

We compared the performance of a chromogenic agar medium chromID VRE (bioMrieux, Marcy-I'Etoile, France) designed to recover and identify vancomycin-resistant enterococci (VRE) from clinical specimens with bile esculin azide vancomycin (BEAV) agar. For this study, 120 stool specimens were plated on chromID VRE and BEAV and examined after 24 and 48 h. At 24 h, the sensitivity and specificity were as follows: BEAV, 90.2% and 73%, respectively; chromID VRE, 86.3% and 100.0%, respectively. Furthermore, we determined that the sensitivity and specificity of chromID VRE for Enterococcus faecium were 85.4% and 100%, respectively, and for Enterococcus faecalis, 90% and 100%, respectively. We conclude that chromID VRE provides an equivalent sensitivity for the recovery of VRE from stool specimens, with improved specificity, and the added advantage of providing differentiation between vancomycin-resistant E.faecium and E. faecalis. (c) 2007 Elsevier Inc. All rights reserved.

引用

页码：477 / 479

页数：3

共 8 条

[1] A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia [J].

Bhavnani, SM ;

Drake, JA ;

Forrest, A ;

Deinhart, JA ;

Jones, RN ;

Biedenbach, DJ ;

Ballow, CH .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 36 (03) :145-158

[2] Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002) [J].

Biedenbach, DJ ;

Moet, GJ ;

Jones, RN .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2004, 50 (01) :59-69

[3] Genetics of glycopeptide resistance in Gram-positive pathogens [J].

Courvalin, P .

INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2005, 294 (08) :479-486

[4]

Gerberding J, 1999, AM J INFECT CONTROL, V27, P520

[5]

Koneman E W., 2006, KONEMANS COLOR ATLAS, P672

[6] Enterococcal bacteremia: Risk factors for vancomycin resistance and predictors of mortality [J].

Lautenbach, E ;

Bilker, WB ;

Brennan, PJ .

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (05) :318-323

[7] Evaluation of a novel chromogenic agar medium for isolation and differentiation of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis isolates [J].

Ledeboer, Nathan A. ;

Das, Kingshuk ;

Eveland, Michael ;

Roger-Dalbert, Celine ;

Mailler, Sandrine ;

Chatellier, Sonia ;

Dunne, William Michael .

JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (05) :1556-1560

[8]

MOELLERING RC, 2005, PRICIPLES PRACTICES, V2

← 1 →